Literature DB >> 28597032

[Leishmaniasis : Diagnosis and therapy].

E von Stebut1.   

Abstract

The delayed appearance of a papule after returning from travelling hints towards the diagnosis cutaneous leishmaniasis. Histologically, a granulomatous inflammatory response is seen, and using Giemsa staining, intracellular parasites can be visualized within histiocytes. Polymer chain reaction (PCR) from the tissue or subsequent cultures not only aids in excluding other differential diagnoses, but also in the identification of the causing Leishmania subspecies. The latter is important for the choice of the optimal therapeutic regimen.

Entities:  

Keywords:  Histology; Inflammation; Papule; Parasites; Polymerase chain reaction

Mesh:

Substances:

Year:  2017        PMID: 28597032     DOI: 10.1007/s00105-017-4001-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study.

Authors:  Omer Bébé Ngouateu; Pierre Kollo; Christophe Ravel; Jacques Dereure; Pierre Kamtchouing; Albert Same-Ekobo; Esther von Stebut; Marcus Maurer; Blaise Dondji
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-01-31       Impact factor: 2.184

Review 2.  [Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy].

Authors:  E von Stebut; U Schleicher; C Bogdan
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

3.  Two cases of successful treatment of multilesional cutaneous leishmaniasis with liposomal amphotericin B.

Authors:  Florian Butsch; Michael Faulde; Andrea Debus; Christian Bogdan; Esther von Stebut
Journal:  J Dtsch Dermatol Ges       Date:  2012-11-26       Impact factor: 5.584

4.  Topical treatment with a two-component gel releasing nitric oxide cures C57BL/6 mice from cutaneous leishmaniasis caused by Leishmania major.

Authors:  Florian Butsch; Beate Lorenz; Alfred Goldinger; Esther von Stebut
Journal:  Exp Dermatol       Date:  2016-11       Impact factor: 3.960

5.  [Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany].

Authors:  Gerhard Boecken; Cord Sunderkötter; Christian Bogdan; Thomas Weitzel; Marcellus Fischer; Andreas Müller; Micha Löbermann; Gerlind Anders; Esther von Stebut; Mirjam Schunk; Gerd Burchard; Martin Grobusch; Ralf Bialek; Gundel Harms-Zwingenberger; Bernhard Fleischer; Mathias Pietras; Michael Faulde; Kay Erkens
Journal:  J Dtsch Dermatol Ges       Date:  2011-11       Impact factor: 5.584

6.  Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells.

Authors:  B Geiger; J Wenzel; M Hantschke; I Haase; S Ständer; E von Stebut
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

7.  A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.

Authors:  Hans-Christian Stahl; Faridullah Ahmadi; Ulrike Schleicher; Rainer Sauerborn; Justo Lorenzo Bermejo; Mohammed Latif Amirih; Ibrahim Sakhayee; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

  7 in total
  2 in total

Review 1.  Immunology and Genetic of Leishmania infantum: The Role of Endonuclease G in the Apoptosis.

Authors:  Mehdi Azami; Vahid Ranjkesh Adermanabadi; Hossein Khanahmad; Mohammad Ali Mohaghegh; Ebtesam Zaherinejad; Maryam Aghaei; Akram Jalali; Seyed Hossein Hejazi
Journal:  J Res Med Sci       Date:  2018-04-26       Impact factor: 1.852

2.  Metagenomic Analysis Identifying a Rare Leishmania Infection in an Adult With AIDS.

Authors:  Pingping Song; Shuai Chen; Xiaoyu Tan; Yanjun Gao; Juanjuan Fu; Zhiqing You; Chengtan Wang; Qigang Zhao; Feng Pang
Journal:  Front Cell Infect Microbiol       Date:  2021-12-15       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.